Orthocell has been featured in The West Australian in an article by Sean Smith titled \u201cOrthocell cracks a new record high.\u201d<\/p>\n
The article highlights the Company\u2019s outstanding recent performance on the ASX, after receiving approval to sell Remplir in Singapore.<\/p>\n
Here’s an excerpt:<\/p>\n
\u201cHaving raised cash at 37\u00a2 and 60\u00a2 a share last year from the likes of Chris Ellison, Rod Jones, the McCusker family and Chris Judd, the fast-running biotech has been among the ASX\u2019s best performers over the past six weeks, cracking $1.50 on Friday to take its gain over the past 12 months to 263 per cent.<\/em><\/p>\n “The shares hit a peak of $1.52 before closing out the shortened trading week 4\u00a2 higher on the day at $1.49, revaluing the University of Western Australia-founded group at $347m.\u201d<\/em><\/p>\n